PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16817498-7	2006	DFS was significantly prolonged in patients treated with PA with respect to IFN.	Protactinium	57-59	interferon alpha 1	Homo sapiens	76-79	
35267550-12	2022	Although pretreatment with IFN-alpha was associated with a shortened median PFS of 81 months (43-118) after PA therapy, this tendency of inferior PFS did not result in inferior OS.	Protactinium	108-110	interferon alpha 1	Homo sapiens	27-36	
9389709-11	1997	The outcome is attributed to IFNalpha therapy, as the Pa methylation status was not reversed in any of the patients treated with hydroxyurea.	Protactinium	54-56	interferon alpha 1	Homo sapiens	29-37